LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
60.46
+5.17 (9.35%)
At close: Nov 24, 2025, 4:00 PM EST
61.50
+1.04 (1.72%)
After-hours: Nov 24, 2025, 7:34 PM EST
LivaNova Revenue
LivaNova had revenue of $357.75M in the quarter ending September 30, 2025, with 12.46% growth. This brings the company's revenue in the last twelve months to $1.35B, up 8.63% year-over-year. In the year 2024, LivaNova had annual revenue of $1.25B with 8.66% growth.
Revenue (ttm)
$1.35B
Revenue Growth
+8.63%
P/S Ratio
2.44
Revenue / Employee
$465,159
Employees
2,900
Market Cap
3.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.25B | 99.89M | 8.66% |
| Dec 31, 2023 | 1.15B | 131.74M | 12.89% |
| Dec 31, 2022 | 1.02B | -13.56M | -1.31% |
| Dec 31, 2021 | 1.04B | 101.12M | 10.82% |
| Dec 31, 2020 | 934.24M | -149.93M | -13.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
LIVN News
- 14 hours ago - LivaNova's VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services - Business Wire
- 12 days ago - LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day - Business Wire
- 19 days ago - LivaNova PLC (LIVN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance - Business Wire
- 4 weeks ago - LivaNova to Present at Wolfe Research Healthcare Conference in November - Business Wire
- 4 weeks ago - LivaNova: Robust Fundamentals, Long-Term Growth Potential - Seeking Alpha
- 6 weeks ago - LivaNova to Announce Third-Quarter 2025 Results - Business Wire
- 6 weeks ago - LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting - Business Wire